Rankings
▼
Calendar
TEVA Q1 2024 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$37B
Q1 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.8B
+4.3% YoY
Gross Profit
$1.8B
46.4% margin
Operating Income
-$218M
-5.7% margin
Net Income
-$139M
-3.6% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
-14.3%
Cash Flow
Operating Cash Flow
-$124M
Free Cash Flow
-$248M
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$42.8B
Total Liabilities
$35.2B
Stockholders' Equity
$7.3B
Cash & Equivalents
$3.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.8B
$3.7B
+4.3%
Gross Profit
$1.8B
$1.6B
+11.9%
Operating Income
-$218M
-$13M
-1576.9%
Net Income
-$139M
-$220M
+36.8%
← FY 2024
All Quarters
Q2 2024 →